The Cooper Companies, Inc. $COO Shares Acquired by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA lifted its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 96.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,099,750 shares of the medical device company’s stock after buying an additional 1,525,693 shares during the period. Massachusetts Financial Services Co. MA owned approximately 1.56% of Cooper Companies worth $212,519,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Maryland State Retirement & Pension System grew its holdings in shares of Cooper Companies by 6.4% during the third quarter. Maryland State Retirement & Pension System now owns 9,704 shares of the medical device company’s stock worth $665,000 after purchasing an additional 581 shares during the last quarter. 4WEALTH Advisors Inc. boosted its position in shares of Cooper Companies by 9.3% in the 3rd quarter. 4WEALTH Advisors Inc. now owns 4,233 shares of the medical device company’s stock valued at $290,000 after purchasing an additional 361 shares during the period. Quent Capital LLC acquired a new position in Cooper Companies during the third quarter worth approximately $44,000. PKO Investment Management Joint Stock Co acquired a new position in Cooper Companies during the third quarter worth approximately $206,000. Finally, Nordea Investment Management AB lifted its stake in Cooper Companies by 9.3% in the third quarter. Nordea Investment Management AB now owns 18,555 shares of the medical device company’s stock valued at $1,261,000 after buying an additional 1,579 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Up 0.1%

Shares of NASDAQ:COO opened at $82.37 on Tuesday. The Cooper Companies, Inc. has a fifty-two week low of $61.78 and a fifty-two week high of $100.24. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30. The firm’s 50-day simple moving average is $79.45 and its 200-day simple moving average is $73.80. The company has a market cap of $16.14 billion, a price-to-earnings ratio of 43.81, a PEG ratio of 2.35 and a beta of 1.03.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.04. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The firm had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.06 billion. During the same period in the prior year, the company posted $1.04 earnings per share. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Insiders Place Their Bets

In other Cooper Companies news, Director Maria Rivas purchased 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 18th. The shares were purchased at an average cost of $82.13 per share, for a total transaction of $82,130.00. Following the completion of the purchase, the director directly owned 11,141 shares in the company, valued at $915,010.33. This represents a 9.86% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Holly R. Sheffield acquired 1,230 shares of the company’s stock in a transaction that occurred on Tuesday, December 16th. The shares were acquired at an average cost of $80.75 per share, for a total transaction of $99,322.50. Following the acquisition, the insider directly owned 39,052 shares of the company’s stock, valued at $3,153,449. This trade represents a 3.25% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders acquired 16,014 shares of company stock worth $1,304,416. Corporate insiders own 1.98% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on COO. Piper Sandler restated an “overweight” rating and set a $94.00 target price (up from $83.00) on shares of Cooper Companies in a research report on Friday, December 5th. Robert W. Baird lifted their price objective on shares of Cooper Companies from $85.00 to $98.00 and gave the company an “outperform” rating in a research note on Friday, December 5th. Mizuho set a $100.00 target price on shares of Cooper Companies and gave the stock an “outperform” rating in a research note on Friday, December 5th. Citigroup restated a “neutral” rating and issued a $88.00 price target (up previously from $72.00) on shares of Cooper Companies in a research report on Monday, December 8th. Finally, JPMorgan Chase & Co. upped their price objective on Cooper Companies from $66.00 to $78.00 and gave the company a “neutral” rating in a research note on Friday, December 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $90.31.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.